Skip to main content
Proacta Spolka Akcyjna logo

Proacta Spolka Akcyjna — Investor Relations & Filings

Ticker · PAC ISIN · PLBTEVL00019 LEI · 2594001SQPVUF46JD857 WAR Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 22 across all filing types
Latest filing 2026-05-12 Major Shareholding Noti…
Country PL Poland
Listing WAR PAC

About Proacta Spolka Akcyjna

http://proacta.pl/

Proacta Spolka Akcyjna is a technology company specializing in bioinformatics and AI-driven solutions for the healthcare and medical sectors. The company develops advanced predictive models using artificial intelligence (AI) and machine learning (ML) to analyze complex medical and genetic data. Its services include creating dedicated software solutions that support clinical decision-making and optimize medical processes. Proacta has expertise in processing and integrating data from various healthcare information systems, such as HIS, LIMS, and EHR/EMR, to generate valuable insights. Key areas of specialization include Medtech, custom software development for healthcare, and providing comprehensive support for research and development (R&D) projects.

Recent filings

Filing Released Lang Actions
Zawiadomienia zgodnie z art. 69 Ustawy o ofercie publicznej
Major Shareholding Notification Classification · 96% confidence The document is a notification by a shareholder under Polish securities law (article 69 and 69a of the Ustawa o ofercie), detailing changes in share ownership percentages from 4.84% to 6.03% following a purchase. This fits the definition of a Major Shareholding Notification, which reports when holdings cross statutory thresholds. There is no indication of an AGM, earnings release, or management discussion; it exclusively reports shareholding levels and the event date. Therefore, the correct classification is MRQ.
2026-05-12 Polish
Zawiadomienia zgodnie z art. 69 Ustawy o ofercie publicznej
Major Shareholding Notification Classification · 92% confidence The document is a notification filed by a direct shareholder under Polish public offering law (art. 69/69a), detailing changes in his shareholding percentages and voting rights. This corresponds to a major shareholding notification rather than a company report, earnings release, or insider director trade. Therefore, the correct filing category is Major Shareholding Notification (MRQ).
2026-05-12 Polish
Otrzymanie zawiadomień o zmianie udziału w ogólnej liczbie głosów Emitenta - Content (PL)
Major Shareholding Notification Classification · 95% confidence The document informs that on 11 May 2026 the company received notifications under Article 69 of the Public Offering Act about a change in the percentage of votes held, and refers to attached notifications. Article 69 disclosures in Polish law relate to thresholds of significant shareholding. This matches a Major Shareholding Notification (MRQ).
2026-05-12 Polish
Zawarcie listu intencyjnego z VeritaMed Sp. z o.o. - Content (PL)
Regulatory Filings Classification · 90% confidence The document is a company announcement about entering into a letter of intent for potential cooperation with another company regarding the pilot implementation and development of a medical platform. It does not contain financial data, regulatory filings, voting results, or any report publication. It is an update on a business collaboration or partnership, which aligns with capital or financing updates or strategic cooperation announcements. However, it is not about fundraising or capital structure changes, so it does not fit CAP. It is not a merger or acquisition. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2026-05-04 Polish
Szacunkowe przychody za I kwartał 2026 roku - Content (PL)
Earnings Release Classification · 85% confidence The document is a Polish disclosure providing preliminary key financial data (estimated Q1 revenues with year-on-year comparison) ahead of the formal interim report. It is not the full interim/quarterly report itself, nor an AGM material, legal/legal notice, nor a notice of dividend, etc. It fits our definition of an Earnings Release (ER) as the initial announcement of quarterly/periodical financial results (key highlights only). Q1 2026
2026-04-23 Polish
Zawarcie istotnej umowy - Content (PL)
Regulatory Filings Classification · 90% confidence The document is a short announcement informing about the execution of a commercial contract for the delivery and implementation of a Digital Breast Cancer Unit system. It does not present financial results, report publication, share transactions, or any financing activity. It is a regulatory announcement disclosing a material contract under MAR but does not fit any specific category such as M&A, financing, share issuance, or dividend. Therefore it falls into the fallback category for miscellaneous regulatory filings.
2026-04-16 Polish

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.